查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1978934

PET-CT掃描儀市場：按設備類型、服務類型、機架類型、應用和最終用戶分類－2026-2032年全球市場預測

PET-CT Scanners Market by Device Type, Service Type, Gantry Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，PET-CT 掃描儀市場價值將達到 29.7 億美元，到 2026 年將成長到 31.3 億美元，到 2032 年將達到 45.7 億美元，複合年成長率為 6.33%。

主要市場統計數據
基準年 2025 29.7億美元
預計年份：2026年 31.3億美元
預測年份 2032 45.7億美元
複合年成長率 (%) 6.33%

PET-CT影像的策略性展望：概述其臨床意義、技術進步以及對醫療保健系統採購和服務提供的影響。

正子斷層掃描（PET-CT）已發展成為一項突破性的影像技術，它融合了功能性和解剖性診斷。 PET-CT能夠同時可視化代謝活動和形態細節，為腫瘤學、循環系統和神經病學等關鍵臨床路徑提供支持，並促進研究和治療診斷學（治療與診斷的整合）。除了臨床價值外，PET-CT系統還在重塑醫院、診斷中心和研究機構的工作流程、資本投資計畫和服務模式。

檢測器創新、人工智慧軟體、不斷發展的示蹤生態系統和新的部署模式如何共同重塑臨床工作流程、採購和服務策略。

在PET-CT系統領域，多項整合變革正在發生，這些變革正在重塑臨床工作流程、供應鏈和商業化策略。檢測器靈敏度和重建技術的快速提升，使得掃描時間得以縮短，病灶檢出更加精準，從而顯著提高了工作流程效率和診斷可靠性。同時，軟體主導的進步，尤其是在人工智慧（AI）和定量成像領域的發展，正在提升整合平台的價值，這些平台能夠提供決策支援、自動化品管和簡化的報告流程。

本研究評估了近期關稅調整對醫療影像硬體和關鍵零件的採購經濟性、供應鏈韌性和籌資策略的影響。

主要經濟體關稅調整的累積效應正在產生一系列營運和策略影響，相關人員應認真考慮。提高醫療影像設備及組件的進口關稅通常會導致最終用戶總體成本上升，迫使採購團隊重新評估總擁有成本 (TCO) 並探索替代籌資策略。由於關稅使某些供應路線在經濟上不利，製造商和供應商可能會加快生產本地化、實現採購地點多元化或重組組件採購系統，以減輕貿易壁壘的影響。

將臨床應用、設備類型、最終用戶需求、服務模式和機架架構與策略決策連結起來的基於細分的洞察。

精準理解產品和服務細分對於將技術交付與臨床應用案例和醫療機構能力相匹配至關重要。從臨床應用角度來看，循環系統、神經和腫瘤領域是明顯的市場需求促進因素。尤其腫瘤領域，其發展日新月異，基於FDG（氟代脫氧葡萄糖）的影像技術支援廣泛的代謝評估，而非FDG示蹤劑則針對特定的生物路徑或受體譜，二者之間存在差異。這些應用層面的差異會影響掃描器的選擇標準、示蹤劑的物流以及影像通訊協定的設計。

美洲、歐洲、中東、非洲和亞太地區的區域特徵會影響不同醫療保健系統的採購選擇、服務模式和追蹤物流。

區域趨勢造就了不同的需求特徵和營運考量，影響相關人員對投資和部署的優先順序。在美洲，醫療保健系統採用多種支付模式和資本化方法，大規模三級醫療機構往往是先進影像技術的早期採用者。因此，整合的工作流程、強大的服務網路以及與放射性示踪劑的廣泛兼容性對於支持複雜的腫瘤學、神經病學和心臟影像項目至關重要。

競爭優勢正在向一個整合平台轉移，該平台結合了硬體效能、軟體智慧、卓越的服務和策略追蹤器夥伴關係。

競爭格局日益受到硬體創新、軟體生態系統和服務卓越性三者交互作用的影響。領先的供應商正在尋求將可擴展的軟體解決方案和平台功能結合的策略，以實現定量成像、工作流程自動化和遠距離診斷。與放射性藥物供應商和研究機構的夥伴關係正成為差異化價值提案的核心，從而能夠提供客製化的示蹤劑支持方案，並產生臨床證據，進而鞏固其在診斷領域的地位。

為製造商、供應商和經銷商提供切實可行的優先建議，以增強供應韌性、擴大服務價值並加速 PET-CT 技術的臨床部署。

為了兼顧臨床影響和商業性價值，產業領導者應採取務實且優先的行動方案，在短期應對能力和長期策略定位之間取得平衡。首先，應實現價值鏈多元化，並評估區域組裝和本地夥伴關係的機會，以降低貿易政策波動帶來的風險，並縮短關鍵備件的前置作業時間。這種務實的做法將增強服務的連續性，並在不同的支付方環境下提供採購柔軟性。

採用透明的混合方法研究途徑，結合一手訪談、技術審查、監管分析和交叉檢驗，確保獲得穩健且可操作的見解。

本報告的研究整合基於混合方法，交叉檢驗了來自一手研究、技術文獻和監管文件的發現。一手研究包括對臨床負責人、影像物理學家、服務經理和採購專家的結構化訪談，揭示了不同醫療機構在營運方面面臨的挑戰、技術重點和決策標準。此外，也參考了設備層面的技術評測、同儕審查文章和已發布的監管文件，以檢驗性能特徵和合規途徑。

結論是：將技術進步、服務模式和政策趨勢與策略挑戰聯繫起來，以最佳化 PET-CT 的採用、臨床價值和韌性。

本執行摘要中的綜合分析表明，PET-CT 仍然是一項至關重要的診斷和研究工具，其策略價值因近期技術和組織變革而得到提升。檢測器技術、重建演算法以及軟體主導的工作流程改進方面的創新正在提高診斷率和營運效率，而示蹤劑的發展趨勢和混合臨床模式正在拓展該技術的臨床應用範圍。同時，貿易政策的變化以及採購、監管和基礎設施的區域差異，正在為不同地區帶來獨特的營運挑戰和策略機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 PET-CT掃描儀市場：依設備類型分類

  • 固定的
  • 移動的

第9章 PET-CT掃描儀市場：依服務類型分類

  • 安裝
  • 維護
  • 升級

第10章：PET-CT掃描儀市場（依機架類型分類）

  • 多切面
  • 單切片

第11章 PET-CT掃描儀市場：按應用領域分類

  • 循環系統
  • 神經病學
  • 腫瘤學
    • FDG示踪劑
    • 非FDG示踪劑

第12章 PET-CT掃描儀市場：依最終用戶分類

  • 診斷中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 研究機構

第13章 PET-CT掃描儀市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 PET-CT掃描儀市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 PET-CT掃描儀市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國PET-CT掃描儀市場

第17章：中國PET-CT掃描儀市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Analogic Corporation
  • Canon Medical Systems Corporation
  • Fujifilm Holdings Corporation
  • General Electric Company
  • Hitachi, Ltd.
  • Koninklijke Philips NV
  • MR Solutions Ltd.
  • Neusoft Medical Systems Co., Ltd.
  • PerkinElmer, Inc.
  • Positron Corporation
  • Segami Corporation
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • United Imaging Healthcare Co., Ltd.
Product Code: MRR-521BAA36EA75

The PET-CT Scanners Market was valued at USD 2.97 billion in 2025 and is projected to grow to USD 3.13 billion in 2026, with a CAGR of 6.33%, reaching USD 4.57 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.97 billion
Estimated Year [2026] USD 3.13 billion
Forecast Year [2032] USD 4.57 billion
CAGR (%) 6.33%

A strategic orientation to PET-CT imaging that frames its clinical relevance, technological evolution, and implications for procurement and service delivery within healthcare systems

Positron emission tomography-computed tomography (PET-CT) has evolved into a cornerstone imaging modality, uniquely positioned at the intersection of functional and anatomical diagnostics. Its capacity to visualize metabolic activity alongside morphological detail underpins crucial clinical pathways across oncology, cardiology, and neurology, while supporting research and theranostic applications. Beyond clinical value, PET-CT systems shape workflows, capital planning, and service models for hospitals, diagnostic centers, and research institutions.

Technological progress in detector materials, image reconstruction algorithms, and integrated software platforms has enhanced image fidelity, scan speed, and quantitative accuracy. These advances, together with growing interest in novel radiotracers and hybrid diagnostic-therapeutic protocols, have redefined expectations for diagnostic yield and patient throughput. As a result, stakeholders must navigate a more complex procurement landscape where device capabilities, tracer ecosystems, and service commitments converge to influence clinical and economic outcomes.

In this context, strategic decision-making requires a holistic view that encompasses device architecture, gantry performance, service and upgrade pathways, and end-user operational needs. The subsequent sections synthesize transformative shifts affecting technology adoption, trade-policy headwinds, segmentation nuances, regional dynamics, competitive imperatives, and actionable steps for leaders. The aim is to provide a structured narrative that supports informed choices across clinical, financial, and regulatory domains.

How detector innovation, AI-enabled software, evolving tracer ecosystems, and new deployment models are jointly reshaping clinical workflows, procurement, and service strategies

The landscape for PET-CT systems is undergoing several convergent shifts that are transforming clinical workflows, supply chains, and commercialization strategies. Rapid improvements in detector sensitivity and reconstruction techniques are enabling shorter scan times and finer lesion detectability, yielding tangible workflow efficiencies and diagnostic confidence. Concurrently, software-driven advancements-particularly in artificial intelligence and quantitative imaging-are increasing the value of integrated platforms that offer decision support, automated quality control, and streamlined reporting.

On the operational front, healthcare providers are evaluating new deployment models that balance fixed installations with mobile or decentralized services to reach underserved populations and optimize scanner utilization. This transition is reinforced by a growing emphasis on service contracts, remote diagnostics, and preventive maintenance programs that preserve uptime and extend asset life. At the same time, the tracer ecosystem is diversifying: while established radiotracers remain central, research into non-FDG agents and theranostic pairs is accelerating, prompting closer collaboration between device manufacturers, radiopharmaceutical suppliers, and clinical teams.

Finally, regulatory expectations and reimbursement frameworks are evolving to address quality assurance, data governance, and value-based care. These changes are encouraging vendors and providers to prioritize interoperable systems, robust documentation, and outcomes-oriented evidence generation. Taken together, these transformative shifts are elevating the role of integrated technology-service partnerships and strategic planning in shaping how PET-CT capabilities are acquired, deployed, and sustained.

Assessing how recent tariff adjustments have altered sourcing economics, supply chain resilience, and procurement strategies for imaging hardware and critical components

The cumulative impact of tariff changes imposed by a major economy has created a set of operational and strategic effects that stakeholders must weigh carefully. Increased import duties on imaging hardware and components typically result in higher landed costs for end users, prompting procurement teams to reassess total cost of ownership considerations and to explore alternative sourcing strategies. As tariffs render some supply routes less economical, manufacturers and suppliers may accelerate localization of manufacturing, diversify sourcing footprints, or reconfigure component sourcing to mitigate exposure to trade barriers.

Beyond immediate cost implications, tariff-driven shifts can introduce friction into existing supply chains, generating longer lead times for critical spare parts and replacement modules. This risk underscores the importance of service resilience and inventory planning for providers that rely on rapid access to components to maintain clinical continuity. Moreover, regulatory compliance and customs procedures can add administrative burden to cross-border transactions, influencing contract terms, warranty structures, and the negotiation of service-level agreements.

In response, stakeholders tend to recalibrate procurement strategies, increase emphasis on modular designs that facilitate local assembly or repair, and strengthen partnerships with regional distributors and service providers. Concurrently, there is a tendency to prioritize devices with lower import intensity or to leverage financing mechanisms that smooth capital expenditure impacts. Taken together, these adaptations demonstrate how trade policy shocks propagate across the ecosystem, affecting capital decisions, service reliability, and the pace at which new technologies are adopted.

Segmentation-driven insights that connect clinical applications, device typologies, end-user requirements, service modalities, and gantry architectures to strategic decision-making

A nuanced understanding of product and service segmentation is essential to align technology offerings with clinical use cases and institutional capabilities. In terms of clinical application, cardiology, neurology, and oncology represent distinct demand drivers; oncology remains particularly dynamic, with differentiation between FDG-based imaging that supports broad metabolic assessment and non-FDG tracers that target specific biological pathways or receptor profiles. These application-level distinctions influence scanner selection criteria, tracer logistics, and the design of imaging protocols.

Device type considerations further refine deployment decisions. Fixed systems typically serve high-volume centers where throughput and comprehensive functionality are priorities, while mobile units provide flexibility for outreach programs and shared-service arrangements among smaller institutions. End-user diversity matters as well: diagnostic centers prioritize throughput and ease of scheduling, hospitals balance inpatient and outpatient workflows and may require integrated electronic health record connectivity, and research institutes value modularity and advanced quantitative capabilities. Within hospital settings, private facilities often emphasize customer experience and value-added service agreements, whereas public hospitals focus on cost-effectiveness and broad access.

Service type choices-installation, maintenance, and upgrades-determine long-term performance and lifecycle economics. Proactive maintenance regimes and structured upgrade paths can extend useful life and preserve image quality, while installation quality affects initial calibration and regulatory compliance. Gantry architecture, whether multi-slice or single-slice, has implications for spatial resolution, scan time, and compatibility with advanced reconstruction techniques. Integrating these segmentation lenses yields a comprehensive foundation for matching product roadmaps and service models to market needs.

Regional nuances across the Americas, Europe-Middle East-Africa, and Asia-Pacific that shape procurement preferences, service models, and tracer logistics across diverse healthcare systems

Regional dynamics create varied demand characteristics and operational considerations that influence how stakeholders prioritize investment and deployment. In the Americas, healthcare systems display a wide spectrum of payer models and capital financing approaches, and large tertiary centers often act as early adopters of advanced imaging modalities. As a result, emphasis is placed on integrated workflows, robust service networks, and compatibility with a range of radiotracers to support complex oncologic, neurologic, and cardiac imaging programs.

The Europe, Middle East & Africa region encompasses diverse regulatory environments and procurement modalities, driving a need for adaptable commercial strategies. In several markets, publicly funded health systems prioritize cost-effective solutions and long-term maintenance agreements, while private centers compete on service differentiation and rapid access. Cross-border collaboration and regional distribution partnerships are common approaches to address logistical challenges and to ensure continuity of tracer supply in markets with limited cyclotron infrastructure.

Asia-Pacific presents a broad mix of rapidly expanding capacity and technology adoption alongside mature centers of excellence. High population density in large metropolitan areas creates demand for scalable solutions, including mobile deployments to extend access to peripheral regions. Additionally, local manufacturing initiatives and strategic alliances between global vendors and regional partners are influencing product localization, regulatory submission timelines, and aftermarket service models. Understanding these regional nuances is essential for aligning product offerings and service footprints with on-the-ground operational realities.

How competitive advantage is shifting toward integrated platforms that combine hardware performance, software intelligence, service excellence, and strategic tracer partnerships

Competitive dynamics are increasingly defined by the interplay between hardware innovation, software ecosystems, and service excellence. Leading suppliers pursue strategies that combine platform performance with scalable software solutions that enable quantitative imaging, workflow automation, and remote diagnostics. Partnerships with radiopharmaceutical suppliers and research institutions are becoming central to differentiated value propositions, enabling tailored tracer-support programs and clinical evidence generation that reinforce diagnostic positioning.

Service and aftermarket offerings represent a growing revenue and differentiation vector. Extended warranties, performance-based service contracts, and remote-monitoring capabilities are being positioned to reduce downtime and provide predictable lifecycle economics for providers. At the same time, modular hardware architectures and upgrade pathways help vendors preserve installed-base relationships while offering incremental feature improvements without complete system replacement.

Collaborative commercialization models-ranging from joint ventures to localized manufacturing and distribution agreements-help vendors address tariff exposures and regulatory complexities in target markets. In parallel, some companies are investing in training and accreditation programs for clinical teams to support advanced protocols and novel tracers, thereby accelerating clinical adoption. Together, these strategic moves indicate that competitive advantage increasingly hinges on integrated solutions that combine technical excellence with service depth, regulatory insight, and clinical partnership.

Practical, prioritized recommendations for manufacturers, providers, and distributors to strengthen supply resilience, expand service value, and accelerate clinical adoption of PET-CT technologies

To capture both clinical impact and commercial value, industry leaders should adopt a set of pragmatic, prioritized actions that balance near-term resilience with long-term positioning. First, diversify supply chains and evaluate opportunities for regional assembly or local partnerships to reduce exposure to trade-policy disruptions and to shorten lead times for critical spares. This pragmatic approach will strengthen service continuity and provide procurement flexibility across different payer environments.

Second, invest in software and analytics capabilities that enhance image quantitation, workflow automation, and remote service diagnostics. These capabilities not only improve diagnostic consistency but also create recurring value through service subscriptions and platform monetization. Third, expand service footprints through preventive maintenance programs, extended warranties, and outcome-oriented service contracts that align vendor incentives with clinical uptime and image quality.

Fourth, pursue tracer and research collaborations to broaden clinical applications beyond conventional agents, supporting theranostic programs and specialty imaging needs. Fifth, tailor commercial models to regional realities by offering modular financing, mobile deployment options, and training programs that build local clinical capacity. Finally, engage proactively with regulators and payers to align evidence generation plans with reimbursement expectations and quality frameworks, ensuring smoother adoption pathways and sustained clinical impact.

A transparent, mixed-methods research approach that blends primary interviews, technical reviews, regulatory analysis, and cross-validation to ensure robust, actionable insights

The research synthesis underpinning this report is grounded in a mixed-methods approach that emphasizes triangulation of primary insights, technical literature, and regulatory documentation. Primary research included structured interviews with clinical leaders, imaging physicists, service managers, and procurement specialists to elicit operational challenges, technology priorities, and decision criteria across diverse care settings. These qualitative inputs were complemented by device-level technical reviews, peer-reviewed publications, and public regulatory filings to validate performance attributes and compliance pathways.

Secondary evidence streams involved analysis of clinical trial registries, tracer development pipelines, and conference proceedings to capture emerging applications and technology directions. Where applicable, anonymized case studies and operational audits informed assessments of installation practices, maintenance regimes, and service model efficacy. Throughout the process, findings were cross-validated with subject-matter experts to ensure accuracy and to surface divergent perspectives.

Limitations were acknowledged and addressed through sensitivity checks and methodological safeguards. Data quality controls included source verification, reviewer adjudication, and a clear audit trail for inferential claims. The methodology emphasizes transparency and reproducibility, providing clients with confidence in the reliability of the insights and the contextual relevance for strategic decision-making.

Concluding synthesis that links technological advances, service models, and policy dynamics to strategic imperatives for optimizing PET-CT deployment, clinical value, and resilience

The synthesis presented throughout this executive summary underscores that PET-CT remains a critical diagnostic and research tool whose strategic value is amplified by recent technological and organizational shifts. Innovations in detector technology, reconstruction algorithms, and software-driven workflow enhancements are increasing diagnostic yield and operational efficiency, while evolving tracer landscapes and hybrid clinical paradigms expand the modality's clinical footprint. At the same time, trade-policy perturbations and regional nuances in procurement, regulation, and infrastructure create differentiated operational challenges and strategic opportunities.

For stakeholders, the imperative is to think holistically: align product design with service offerings, build supply chains that reduce exposure to external shocks, and invest in software and clinical partnerships that generate sustained value. By doing so, manufacturers, providers, and distributors can ensure that PET-CT capabilities deliver both improved patient outcomes and predictable operational performance. The insights and recommendations in this report are intended to inform capital allocation, product roadmaps, and collaborative strategies that will shape the next phase of PET-CT adoption and clinical integration.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. PET-CT Scanners Market, by Device Type

  • 8.1. Fixed
  • 8.2. Mobile

9. PET-CT Scanners Market, by Service Type

  • 9.1. Installation
  • 9.2. Maintenance
  • 9.3. Upgrades

10. PET-CT Scanners Market, by Gantry Type

  • 10.1. Multi-Slice
  • 10.2. Single-Slice

11. PET-CT Scanners Market, by Application

  • 11.1. Cardiology
  • 11.2. Neurology
  • 11.3. Oncology
    • 11.3.1. FDG Tracer
    • 11.3.2. Non-FDG Tracer

12. PET-CT Scanners Market, by End User

  • 12.1. Diagnostic Centers
  • 12.2. Hospitals
    • 12.2.1. Private Hospitals
    • 12.2.2. Public Hospitals
  • 12.3. Research Institutes

13. PET-CT Scanners Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. PET-CT Scanners Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. PET-CT Scanners Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States PET-CT Scanners Market

17. China PET-CT Scanners Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Analogic Corporation
  • 18.6. Canon Medical Systems Corporation
  • 18.7. Fujifilm Holdings Corporation
  • 18.8. General Electric Company
  • 18.9. Hitachi, Ltd.
  • 18.10. Koninklijke Philips N.V.
  • 18.11. MR Solutions Ltd.
  • 18.12. Neusoft Medical Systems Co., Ltd.
  • 18.13. PerkinElmer, Inc.
  • 18.14. Positron Corporation
  • 18.15. Segami Corporation
  • 18.16. Shimadzu Corporation
  • 18.17. Siemens Healthineers AG
  • 18.18. United Imaging Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PET-CT SCANNERS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PET-CT SCANNERS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PET-CT SCANNERS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PET-CT SCANNERS MARKET SIZE, BY INSTALLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PET-CT SCANNERS MARKET SIZE, BY UPGRADES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PET-CT SCANNERS MARKET SIZE, BY MULTI-SLICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PET-CT SCANNERS MARKET SIZE, BY SINGLE-SLICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET-CT SCANNERS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PET-CT SCANNERS MARKET SIZE, BY FDG TRACER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PET-CT SCANNERS MARKET SIZE, BY NON-FDG TRACER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PET-CT SCANNERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PET-CT SCANNERS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PET-CT SCANNERS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PET-CT SCANNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PET-CT SCANNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. GCC PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GCC PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GCC PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. GCC PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. GCC PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. G7 PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. G7 PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. G7 PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. G7 PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. G7 PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. G7 PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. G7 PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 166. NATO PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. NATO PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NATO PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. NATO PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. NATO PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NATO PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. NATO PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL PET-CT SCANNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA PET-CT SCANNERS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA PET-CT SCANNERS MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA PET-CT SCANNERS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA PET-CT SCANNERS MARKET SIZE, BY GANTRY TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA PET-CT SCANNERS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA PET-CT SCANNERS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA PET-CT SCANNERS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA PET-CT SCANNERS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)